R. Prescott et al., THE INHIBITOR ANTIBODY-RESPONSE IS MORE COMPLEX IN HEMOPHILIA-A PATIENTS THAN IN MOST NONHEMOPHILIACS WITH FACTOR-VIII AUTOANTIBODIES, Blood, 89(10), 1997, pp. 3663-3671
Approximately 25% of hemophilia A patients infused with factor VIII (f
VIII) mount an immune response, which leads to its inactivation. Anti-
fVIII autoantibodies are also seen rarely in individuals with normal f
VIII, We have previously demonstrated that some anti-A2 and anti-C2 do
main antibodies are fVIII inhibitors and that many patients have addit
ional inhibitors with a fVIII light chain (LCh) epitope outside C2. Be
cause the contribution of the different antibodies to the plasma inhib
itor titer had been examined in a limited number of patients (14), we
report in this study a more extensive analysis of 55 plasmas, The domi
nant inhibitors in 62% (13 of 21) of autoantibody plasmas were directe
d only against C2 or A2, but not both, whereas this pattern was found
in only 15% (5 of 34) of hemophilic plasmas. In addition, anti-A2 inhi
bitors were present in 71% (24 of 34) of hemophilic plasmas, but only
33% (7 of 21) of autoantibody plasmas. These results demonstrated that
the inhibitor response In hemophiliacs was more complex and the epito
pe specificity was somewhat different. A comparison of hemophiliacs tr
eated only with plasma fVIII or recombinant fVIII showed no significan
t differences in the complexity of the inhibitor response, as greater
than or equal to 2 different inhibitor antibodies were present in 78%
(18 of 23) of the former and 82% (9 of 11) of the latter. In contrast,
the major inhibitors in 35% (8 of 23) of hemophiliacs treated with pl
asma fVIII were directed against C2 and another LCh epitope within res
idues 1649-2137, but not A2, while none (0 of 11) treated with recombi
nant fVIII had this pattern. (C) 1997 by The American Society of Hemat
ology.